Surprisingly, several studies have demonstrated that ODC inhibition [133,134,135,136], and/or treatment with polyamine transport inhibitors (PTIs) significantly reduces rates of tumor growth and that this is due to increase in anti-tumor immunity. The gene discussed is ODC1; the disease is neoplasm.